Suministro de medicamentos exclusivos con principios activos abrocitinib, albutrepenonacog alfa, cemiplimab, cloruro de maralixibat, elranatamab, melfalan flufenamida, mosunetuzumab, nirmatrelvir/ritonavir, rimegepant, rucaparib, tucatinib, veneno de abeja, veneno de avispa y zanubrutinib,

Contract type	Supplies
CPV	33690000
Awarded to	ROCHE FARMA, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.